28 Feb 2014
Clariant's Annual Report 2013 is now available
Muttenz, February 28, 2014 - Clariant, a world leader in specialty chemicals, today published its Annual Report 2013. The report is now available in German and English language on www.clariant.com. In addition the report can also be ordered as a hard copy via company website.
26 Feb 2014
Clariant focuses on benchmark sustainable technology for high-power electric vehicle batteries
Muttenz, February 26, 2014 - Clariant, a world leader in specialty chemicals, is focusing on its pioneering Wet Process Technology to ensure benchmark quality, premium lithium-iron phosphate cathode materials for automotive OEMs and battery manufacturers.
24 Feb 2014
Clariant Container Dri® II Desiccants Meet New FCC Guidelines for Cocoa Bean Shipments
Muttenz, February 24, 2014 – Clariant, a world leader in specialty chemicals, today announced that its Container Dri® II desiccant products meet new specifications from the Federation of Cocoa Commerce Ltd. (FCC) for protection of cocoa bean shipments in containers. The updated FCC guidelines, published in November 2013, no longer recommend silica gel desiccant bags; instead, they now recommend calcium chloride desiccant bags with a minimum loading of 65 percent. Clariant’s Container Dri II desiccants not only meet these recommendations with a 65 percent or higher loading, but also provide the highest moisture absorption of any calcium chloride-based product. They easily address FCC absorption requirements and provide a cost-effective solution for cocoa bean shippers. Container Dri II desiccants are already providing excellent results for coffee shippers.
19 Feb 2014
Clariant continues on profitable growth path in 2013
“Clariant has made good progress in 2013. The unfolding operational strength of the company became visible in a challenging economic environment. After the divestment of several businesses, Clariant is now a more profitable, less cyclical and well-balanced specialty chemicals player,” said CEO Hariolf Kottmann. “2014 will be a year of organic growth in the four Business Areas. This will bring us closer to our mid-term target to position Clariant in the top-tier of the specialty chemicals industry, characterized by an EBITDA margin before exceptionals between 16% and 19% in 2015 and beyond.”
12 Feb 2014
Clariant Healthcare Packaging promotes growing capacities and product offerings at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 - Clariant, a world leader in specialty chemicals, represented by its business line Healthcare Packaging, will exhibit its expanding portfolio of protective packaging for pharmaceuticals at Pharmapack Europe 2014 Paris. A long time leader in pharmaceutical desiccants, oxygen scavengers and specialized container closure systems, Clariant Healthcare Packaging, along with Clariant Medical Masterbatches, will once again present its solutions to customers at PharmaPack.
12 Feb 2014
Clariant Healthcare Packaging Collaborates with Pumpart for Airless Technologies for Protecting Pharmaceutical Creams
Muttenz, February 12, 2014 - Clariant, a world leader in specialty chemicals, through its Healthcare Packaging business segment, has announced a partnership and collaboration with PumpArt System® for the introduction of an innovative airless dispensing technology, Tubairless®, to the pharmaceutical industry.
12 Feb 2014
Clariant supports the ocular medicine packaging with launch of new global and compliant standard color range of masterbatches for caps and closures at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, In the Healthcare sector, coloration of plastics plays an important role in protecting patients by identifying drug types or doses, thereby reducing the risk of errors. However, these plastic packaging materials and the colorants in them need assessment of how they behave in contact with the drug during storage and use. These extractable and leachable studies on the packaging material, play an important role in medium and high risk applications such as ocular medicines, but if something changes in the polymers or masterbatches used to manufacture the packaging, then the data from the extractable and leachable studies may no longer be valid. To address these issues Clariant has used in dedicated expertise to create a new range of standard masterbatch colors, offering the benefits of the MEVOPUR® brand, tailored to the color standard developed by the American Society of Ophthalmology.
12 Feb 2014
Clariant opens the door for productivity and sustainability in pharmaceutical packaging with European Pharmacopeia tested additives
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, supports the Healthcare industry with a range of products developed for medical devices and pharmaceutical plastic packaging. With its knowledge, Clariant’s MEVOPUR® nucleant product brings improvements in the process of plastic packaging fabrication. Thanks to them the processing time can be reduced; mechanical properties improved and so companies can save time and increase the productivity. The nucleating agents used in MEVOPUR products are pre-tested using extraction protocols such as those established by US Pharmacopeia, ISO and NEW European Pharmacopeia monograph 3.1.3; the goal is helping companies to meet the challenging regulatory requirements to support “Controlled, Consistent and Compliant”.
12 Feb 2014
Clariant launches new ‘EP’ masterbatch range for pharmaceutical packaging at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, a world leader in specialty chemicals, Since the launch of the MEVOPUR® range of masterbatch and compounds for Healthcare applications at the end of 2010, Clariant has been active in bring new ideas and products to the market, with the objective of ‘Enhancing Products and Process’ and ‘Protecting the Patient and the Drug’. In particular in the last 12 months, new additive masterbatches have attracted high interest because Clariant had pre-tested the raw materials for the masterbatches using the extraction and biological evaluation protocols of US Pharmacopeia (USP) 23 parts 87 and 88. However initial feed-back raised the question of whether the substances were also listed European Pharmacopeia chapter 3.1.3 (EP 3.1.3). Clariant has reacted to this feed-back and recently completed a test programme on raw materials of its masterbatches, and is now offering products that use raw materials that have been pre-evaluated to both the above USP and EP standards.
12 Feb 2014
Clariant un-taps creativity potential for the healthcare sector at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, a world leader in specialty chemicals, continues to demonstrate that it is possible to combine creativity with enhanced protection and processing performance for healthcare applications with its sector-dedicated MEVOPUR® polymer and packaging solutions at Pharmapack Europe 2014 Paris (booth 330). MEVOPUR color and performance additives are developed and produced at three ISO 13485 certified and dedicated production facilities located in USA, Europe and Asia to ensure ‘Controlled, Consistent and Compliant’ innovations for the industry.
12 Feb 2014
Clariant continues investment into new product innovations at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, a world leader in specialty chemicals, continues to demonstrate that it is possible to combine creativity with enhanced protection and processing performance for healthcare applications with its sector-dedicated MEVOPUR® polymer and packaging solutions at Pharmapack Europe 2014 Paris (booth 330). MEVOPUR color and performance additives are developed and produced at three ISO 13485 certified and dedicated production facilities located in USA, Europe and Asia to ensure ‘Controlled, Consistent and Compliant’ innovations for the industry.
11 Feb 2014
Clariant Divests its Water Treatment Business to South African AECI
Muttenz, February 11, 2014 - Clariant, a world leader in specialty chemicals, today announced that it has signed an agreement to divest the Water Treatment business in Africa to AECI, domiciled in South Africa. The total consideration of the sale amounts to CHF 34 million in cash at closing that is expected by the end of the second quarter 2014. The transaction is subject to certain conditions precedent, as well as regulatory approvals.
